Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial
- 1 March 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (3) , 461-468
- https://doi.org/10.1067/mai.2001.114657
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 1999
- First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthmaThorax, 1998
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Effects of Leukotriene D on the Airways in AsthmaNew England Journal of Medicine, 1983
- Bronchoconstrictor Effects of Leukotriene C in HumansScience, 1982